文献速递艾滋病与性传播感染结核与非结核分枝杆菌

晚期人类免疫缺陷病毒(HIV)感染者的重型分枝杆菌免疫重建炎症综合征(IRIS)具有噬血细胞性淋巴组织细胞增生症(HLH)特征且需延长免疫抑制

Severe Mycobacterial Immune Reconstitution Inflammatory Syndrome (IRIS) in Advanced Human Immunodeficiency Virus (HIV) Has Features of Hemophagocytic Lymphohistiocytosis and Requires Prolonged Immune Suppression.
PubMed 文献 · Clin Infect Dis · 2023-01-01

在80例CD4<100 cells/µL的HIV合并分枝杆菌感染患者中,符合HLH标准的IRIS(HLH-IRIS)较非HLH-IRIS更频繁使用糖皮质激素(OR 21.5,95%CI 5.6-114.8)且疗程更长(21.2周,95%CI 10.7-31.7周)。ART前血红蛋白<9.2 g/dL是HLH-IRIS的最佳预测指标,IRIS发生时铁蛋白、CXCL9和sCD25对HLH诊断价值最高。研究提示重型分枝杆菌IRIS与HLH存在重叠发病机制。

要点

  • HLH-IRIS患者较非HLH-IRIS更频繁使用糖皮质激素(OR 21.5,95%CI 5.6-114.8)且疗程更长(21.2周,95%CI 10.7-31.7周)。
  • ART前血红蛋白<9.2 g/dL是HLH-IRIS的最佳预测指标。
  • IRIS发生时铁蛋白、CXCL9和sCD25对HLH诊断价值最高。

核心结论

  • 重型分枝杆菌IRIS与HLH具有重叠发病机制,涉及IFNγ和不受拮抗的T细胞活化,临床上以高铁蛋白血症为特征(高铁路蛋白IRIS,FIRIS)。
  • 血红蛋白、铁蛋白、CXCL9和sCD25可识别高危患者,并可能改善分枝杆菌IRIS的风险分层和治疗策略。

研究设计与样本

  • 对80例CD4<100 cells/µL的HIV合并分枝杆菌感染患者进行纵向队列研究,应用HLH标准将患者分为符合HLH标准的IRIS(HLH-IRIS)、不符合HLH的IRIS(IRIS)和无IRIS(non-IRIS)三组。
  • 临床结局通过回归分析评估,可溶性生物标志物和T细胞亚群在基线和IRIS等效时间点检测。

主要发现

  • HLH-IRIS患者较不符合HLH标准者更频繁需要糖皮质激素(OR 21.5;95%CI 5.6-114.8)且疗程更长(21.2;95%CI 10.7-31.7周)。
  • 决策树分析显示,ART前血红蛋白<9.2 g/dL是HLH-IRIS的最佳预测指标,而IRIS发生时铁蛋白、CXCL9和sCD25对HLH诊断价值最高。
  • 在IRIS时间点而非基线,HLH-IRIS患者较IRIS和non-IRIS两组调节性T细胞更低、活化T细胞更高,且IFNγ-IL-18轴生物标志物产生更多。
  • 主成分分析证实HLH-IRIS患者存在独特聚类。

关键数值与推荐

  • HLH-IRIS患者需要糖皮质激素的OR为21.5(95%CI 5.6-114.8),疗程为21.2周(95%CI 10.7-31.7周)。
  • ART前血红蛋白<9.2 g/dL是HLH-IRIS的最佳预测指标。
  • IRIS发生时铁蛋白、CXCL9和sCD25对HLH诊断价值最高。

临床怎么用

  • 血红蛋白、铁蛋白、CXCL9和sCD25可能改善分枝杆菌IRIS的风险分层和治疗策略(作者结论)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People with HIV and mycobacterial infections can develop immune reconstitution inflammatory syndrome (IRIS) after starting antiretroviral therapy (ART). Severe mycobacterial IRIS has an overlapping clinical phenotype with hemophagocytic lymphohistiocytosis (HLH). We evaluated the pathophysiologic similarities between mycobacterial IRIS and HLH to identify clinical and immune predictors of mycobacterial IRIS severity. METHODS: HLH criteria were applied to a longitudinal cohort of 80 patients with HIV (CD4 <100 cells/µL) and mycobacterial infections. Participants were subdivided into IRIS meeting HLH criteria (HLH-IRIS), IRIS without HLH (IRIS), and those without IRIS (non-IRIS). Clinical outcomes were evaluated by regression analyses. Soluble biomarkers and T-cell subsets were assessed at baseline and IRIS-equivalent time points. RESULTS: HLH-IRIS patients required corticosteroids more frequently (OR: 21.5; 95%CI: 5.6-114.8) and for longer duration (21.2; 95%CI: 10.7-31.7 weeks) than those not meeting HLH criteria. Utilizing decision tree analyses, hemoglobin <9.2 g/dL was the best predictor of HLH-IRIS before ART, whereas ferritin, CXCL9 and sCD25 were most diagnostic for HLH at IRIS onset. At the IRIS timepoint, but not baseline, HLH-IRIS patients had lower regulatory and higher activated T cells along with greater production of IFNγ-IL-18 axis biomarkers compared with both IRIS and non-IRIS groups. Principal component analysis corroborated the distinct clustering of HLH-IRIS patients. CONCLUSIONS: Severe mycobacterial IRIS and HLH have an overlapping pathogenesis involving IFNγ and unopposed T-cell activation causing severe inflammatory disease clinically distinguished by hyperferritinemia (hyperferritinemic IRIS [FIRIS]). Hemoglobin, ferritin, CXCL9, and sCD25 identify high-risk patients and may improve risk stratification and therapeutic strategies for mycobacterial IRIS.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Rocco JM, Laidlaw E, Galindo F, et al. Severe Mycobacterial Immune Reconstitution Inflammatory Syndrome (IRIS) in Advanced Human Immunodeficiency Virus (HIV) Has Features of Hemophagocytic Lymphohistiocytosis and Requires Prolonged Immune Suppression. Clin Infect Dis. 2023. PMID: 36048425. doi:10.1093/cid/ciac717

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。